JP2025511845A5 - - Google Patents

Info

Publication number
JP2025511845A5
JP2025511845A5 JP2024559381A JP2024559381A JP2025511845A5 JP 2025511845 A5 JP2025511845 A5 JP 2025511845A5 JP 2024559381 A JP2024559381 A JP 2024559381A JP 2024559381 A JP2024559381 A JP 2024559381A JP 2025511845 A5 JP2025511845 A5 JP 2025511845A5
Authority
JP
Japan
Prior art keywords
lipid
binding protein
based complex
eye
subject
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024559381A
Other languages
English (en)
Japanese (ja)
Other versions
JP2025511845A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IB2023/000181 external-priority patent/WO2023194797A1/en
Publication of JP2025511845A publication Critical patent/JP2025511845A/ja
Publication of JP2025511845A5 publication Critical patent/JP2025511845A5/ja
Pending legal-status Critical Current

Links

JP2024559381A 2022-04-06 2023-04-06 脂質結合タンパク質ベースの複合体を使用した、眼疾患を治療するための方法 Pending JP2025511845A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202263328088P 2022-04-06 2022-04-06
US63/328,088 2022-04-06
PCT/IB2023/000181 WO2023194797A1 (en) 2022-04-06 2023-04-06 Methods for treating eye diseases using lipid binding protein-based complexes

Publications (2)

Publication Number Publication Date
JP2025511845A JP2025511845A (ja) 2025-04-16
JP2025511845A5 true JP2025511845A5 (cg-RX-API-DMAC7.html) 2026-04-14

Family

ID=86732194

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024559381A Pending JP2025511845A (ja) 2022-04-06 2023-04-06 脂質結合タンパク質ベースの複合体を使用した、眼疾患を治療するための方法

Country Status (10)

Country Link
US (2) US20250230208A1 (cg-RX-API-DMAC7.html)
EP (1) EP4504150A1 (cg-RX-API-DMAC7.html)
JP (1) JP2025511845A (cg-RX-API-DMAC7.html)
KR (1) KR20240167701A (cg-RX-API-DMAC7.html)
CN (1) CN119384269A (cg-RX-API-DMAC7.html)
AU (1) AU2023250345A1 (cg-RX-API-DMAC7.html)
CA (1) CA3247589A1 (cg-RX-API-DMAC7.html)
IL (1) IL316110A (cg-RX-API-DMAC7.html)
MX (1) MX2024012303A (cg-RX-API-DMAC7.html)
WO (1) WO2023194797A1 (cg-RX-API-DMAC7.html)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US12343810B1 (en) * 2023-09-08 2025-07-01 Chris S. Capkovic Wire coil stabilizer and saw guide

Family Cites Families (69)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US233953A (en) * 1880-11-02 Wabben h
US1958203A (en) * 1930-07-19 1934-05-08 Arthur C Pfau Routing machine
US2660079A (en) * 1951-03-26 1953-11-24 Foy E Bellows Hand supportable clamp and bench mount therefor
US3484095A (en) * 1968-02-08 1969-12-16 Maurice S Park Jeweler's bench work clamp
US4044805A (en) * 1976-02-04 1977-08-30 Gronholz Donald D Router guide unit
US4281694A (en) * 1979-11-05 1981-08-04 Gorman Thomas E Cutting guide for a router or similar tool
US4353672A (en) * 1980-06-09 1982-10-12 Smith Gerald T Template device
CH661233A5 (de) * 1983-02-28 1987-07-15 Agie Ag Ind Elektronik Werkstueckpalette an werkzeugmaschinen.
US4824066A (en) * 1983-04-11 1989-04-25 Smith S Gregory Apparatus for aiding in the storing and preserving of donor corneas
US4549727A (en) * 1983-09-26 1985-10-29 Kozar John J Lazy susan vise
US4880935A (en) 1986-07-11 1989-11-14 Icrf (Patents) Limited Heterobifunctional linking agents derived from N-succinimido-dithio-alpha methyl-methylene-benzoates
US5128318A (en) 1987-05-20 1992-07-07 The Rogosin Institute Reconstituted HDL particles and uses thereof
GB8712540D0 (en) 1987-05-28 1987-07-01 Ucb Sa Expression of human proapolipoprotein a-i
IL89220A (en) 1988-02-11 1994-02-27 Bristol Myers Squibb Co Anthracycline immunoconjugates, their production and pharmaceutical compositions containing them
US5208020A (en) 1989-10-25 1993-05-04 Immunogen Inc. Cytotoxic agents comprising maytansinoids and their therapeutic use
US5052454A (en) * 1990-10-18 1991-10-01 Meinhardt Gregory J Guide system for routers
US5094279A (en) * 1991-01-07 1992-03-10 Dickey John W Coping jig
US5220043A (en) 1991-03-21 1993-06-15 Ohio University Synthesis of D-erythro-sphingomyelins
SE9103701D0 (sv) 1991-12-13 1991-12-13 Kabi Pharmacia Ab Apolipoprotein
US5622929A (en) 1992-01-23 1997-04-22 Bristol-Myers Squibb Company Thioether conjugates
US5513594A (en) * 1993-10-20 1996-05-07 Mcclanahan; Adolphus E. Clamp with wafer release for semiconductor wafer processing equipment
EP0751961A1 (en) 1994-03-22 1997-01-08 Research Corporation Technologies, Inc. Eating suppressant peptides
US5577717A (en) * 1995-05-30 1996-11-26 Benson; Donald M. Jeweler's saw vise
EP0871490B1 (en) 1995-12-22 2003-03-19 Bristol-Myers Squibb Company Branched hydrazone linkers
US5715589A (en) * 1995-12-29 1998-02-10 Teague; Tyler Jewelry fixture and method
US5578167A (en) * 1996-01-31 1996-11-26 Motorola, Inc. Substrate holder and method of use
US6046166A (en) 1997-09-29 2000-04-04 Jean-Louis Dasseux Apolipoprotein A-I agonists and their use to treat dyslipidemic disorders
US6004925A (en) 1997-09-29 1999-12-21 J. L. Dasseux Apolipoprotein A-I agonists and their use to treat dyslipidemic disorders
US6037323A (en) 1997-09-29 2000-03-14 Jean-Louis Dasseux Apolipoprotein A-I agonists and their use to treat dyslipidemic disorders
US5983968A (en) * 1998-12-09 1999-11-16 Newman; Roger R. Router base adapter unit for small templates
DK1290013T3 (da) 2000-04-21 2006-06-26 Amgen Inc Apo-A1/All-peptidderivater
US6664230B1 (en) 2000-08-24 2003-12-16 The Regents Of The University Of California Orally administered peptides to ameliorate atherosclerosis
US7148197B2 (en) 2000-08-24 2006-12-12 The Regents Of The University Of California Orally administered small peptides synergize statin activity
US7199102B2 (en) 2000-08-24 2007-04-03 The Regents Of The University Of California Orally administered peptides synergize statin activity
US8568766B2 (en) * 2000-08-24 2013-10-29 Gattadahalli M. Anantharamaiah Peptides and peptide mimetics to treat pathologies associated with eye disease
US7144862B2 (en) 2000-08-24 2006-12-05 The Regents Of The University Of California Orally administered peptides to ameliorate atherosclerosis
WO2002038609A2 (en) 2000-11-10 2002-05-16 Proteopharma Aps Apolipoprotein conjugates
US7217785B2 (en) 2001-05-09 2007-05-15 The Regents Of The University Of California Cysteine-containing peptides having antioxidant properties
ES2304452T3 (es) 2001-08-20 2008-10-16 Csl Behring Ag Una hdl para el tratamiento de un ictus y de otras condiciones isquemicas.
US20030113180A1 (en) * 2001-11-09 2003-06-19 Karl-Heinz Schelberg Milling system and method
US7223726B2 (en) 2002-01-14 2007-05-29 The Regents Of The University Of California Apolipoprotein A-I mutant proteins having cysteine substitutions and polynucleotides encoding same
MXPA04011312A (es) 2002-05-17 2005-02-14 Esperion Therapeutics Inc Metodo para el tratamiento de desordenes dislipidemicos.
US6752572B2 (en) * 2002-06-07 2004-06-22 S-B Power Tool Corporation Circle cutting accessory for a powered rotary hand tool
US6953840B2 (en) 2002-07-30 2005-10-11 Esperion Therapeutics, Inc. Methods of using non-human animal Apolipoprotein A-I protein
WO2004073684A2 (en) 2003-02-14 2004-09-02 Children's Hospital & Research Center At Oakland Lipophilic drug delivery vehicle and methods of use thereof
JP5048486B2 (ja) 2004-07-16 2012-10-17 トラスティーズ オブ タフツ カレッジ アポリポタンパク質a1の模倣物とその使用
US8206750B2 (en) 2005-03-24 2012-06-26 Cerenis Therapeutics Holding S.A. Charged lipoprotein complexes and their uses
BRPI0614966A2 (pt) 2005-08-26 2016-09-13 Cerenis Therapeutics Holding S A vetor de expressão, bactéria de ácido lático, apolipoproteína isenta de endotoxina, e, método de produção de uma apolipoproteína isenta de endotoxina
US8541236B2 (en) 2006-12-08 2013-09-24 University Of Washington Mutant apolipoprotein A-1 polypeptide with increased resistance to oxidation and reactive carbonyls
WO2008104890A2 (en) 2007-02-28 2008-09-04 Cerenis Therapeutics Holding Sa Compositions and methods for producing apolipoprotein
US9173890B2 (en) 2007-09-20 2015-11-03 Abbott Cardiovascular Systems Inc. Sustained release of Apo A-I mimetic peptides and methods of treatment
ES2601830T3 (es) 2007-10-23 2017-02-16 The Cleveland Clinic Foundation Apolipoproteína A-1 resistente a oxidantes y péptidos miméticos
MX2011008599A (es) 2009-02-16 2011-11-18 Cerenis Therapeutics Sa Peptidos mimeticos de la apolipoproteina a-i.
WO2011143362A1 (en) 2010-05-11 2011-11-17 Esperion Therapeutics, Inc. Dimeric oxidation-resistant apolipoprotein a1 variants
LT2673296T (lt) 2011-02-07 2019-02-25 Cerenis Therapeutics Holding Sa Lipoproteino kompleksai ir jų gamyba ir jų panaudojimai
US9726469B2 (en) * 2012-08-31 2017-08-08 Nomis Llc Turnlock small circle compass attachment
US9708354B2 (en) 2013-03-15 2017-07-18 Cerenis Therapeutics Holding Sa Methods for the synthesis of sphingomyelins and dihydrosphingomyelins
SG11201506456VA (en) 2013-03-15 2015-09-29 Cerenis Therapeutics Holding Sa Methods for the synthesis of sphingomyelins and dihydrosphingomyelins
RU2016144908A (ru) 2014-05-02 2018-06-05 Серени Терапеутикс Холдинг Са Маркеры hdl-терапии
US11129900B2 (en) 2014-12-25 2021-09-28 Kyoto University Cytophilic peptide-fused high-density lipoprotein, and delivery of drug to posterior segment of eye by ocular installation of said fusion
CN110545836A (zh) * 2017-01-24 2019-12-06 马克雷根有限公司 用载脂蛋白模拟物治疗与年龄有关的黄斑变性和其他眼部疾病
US11173624B2 (en) * 2017-05-09 2021-11-16 Nomis Llc Router base having adjustable mounting slots
US10905770B2 (en) 2017-07-17 2021-02-02 Macregen, Inc. Topical delivery of therapeutic agents using cell-penetrating peptides for the treatment of age-related macular degeneration and other eye diseases
US20190046608A1 (en) 2017-08-10 2019-02-14 Cerenis Therapeutics Holding Sa Apomers
TW201919712A (zh) 2017-08-10 2019-06-01 法商塞勒尼斯醫療控股公司 運送子(cargomers)
US20210031333A1 (en) * 2019-08-01 2021-02-04 Swanstrom Tools Usa Inc. Clamp assembly
US11433465B2 (en) * 2021-01-22 2022-09-06 Christopher A. Hentz Ring cutting jig
US11383356B1 (en) * 2021-02-16 2022-07-12 Dennis J. Montilepre System and method for easy rotational jewelry metal clamp
US12343810B1 (en) * 2023-09-08 2025-07-01 Chris S. Capkovic Wire coil stabilizer and saw guide

Similar Documents

Publication Publication Date Title
JP7368661B2 (ja) 医薬組成物
US20220184057A1 (en) Combination treatment of ocular inflammatory disorders and diseases
KR102373259B1 (ko) 개선된 점막 수송을 나타내는 제약 나노입자
JP7547411B2 (ja) 局所用シクロスポリン含有製剤およびその使用
AU2011284589B2 (en) Compounds for the treatment/prevention of ocular inflammatory diseases
CN114245737A (zh) 微乳剂组合物
JP2019038825A (ja) 治療用化合物の結晶形態及びその使用
JP2010536797A5 (cg-RX-API-DMAC7.html)
JP2023543498A5 (cg-RX-API-DMAC7.html)
JP2024534570A (ja) 眼炎症性疾患を処置する方法
US12115246B2 (en) Compositions and methods for ophthalmic and/or other applications
JP2022554277A (ja) エンドセリンレセプターアンタゴニストを使用する眼疾患の処置
JP2019038824A (ja) 治療用化合物の結晶形態及びその使用
US10864219B2 (en) Compositions and methods for ophthalmic and/or other applications
JP2024506384A (ja) ロフルミラストの眼科的送達方法
KR20260046153A (ko) 전방 및 망막-유리체 챔버 안구 질환의 치료를 위한 로플루밀라스트의 안구 표면 국소 투여
HK40039407A (en) Compositions and methods for ophthalmic and/or other applications
HK40038231A (en) Pharmaceutical nanoparticles showing improved mucosal transport
GUPTA STUDIES ON IN SITU GELLING SYSTEM FOR BETTER OCULAR DRUG THERAPY
HK1226949A1 (en) Compositions and methods for ophthalmic and/or other applications